Menu
Recruiting NCT05652361

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery

No phase Interventional Rectum Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Additional visualisation of surgical assistance during surgery.
Who it may be relevant to
Registry conditions: Rectum Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery - a First-in-human Interventional Study

Overview

The aim of the study is to evaluate the technical feasibility and applicability of a surgical assistance system based on image recognition algorithms in a first-in-human pilot study. In addition, this study will provide preliminary data on the oncological outcome of the assistance system.

Interventions

  • Other Additional visualisation of surgical assistance during surgery
    Robot-assisted anterior rectal resection using daVinci® system as CE-marked gold standard with additional visualization of surgical assistance functions based on machine learning techniques

Primary outcome measures

  • Incidence of discrepancies between the surgeon's preparation and the prediction of the CoBot system [Time frame: 72 hours after Surgery]
Secondary outcome measures (11)
  • Operating time [min] [Time frame: During Surgery]
  • Duration of postoperative hospital stay [days] [Time frame: At day of discharge, assessed up to 5 days]
  • Duration of postoperative intermediate/intensive care unit stay [days] [Time frame: At day of discharge, assessed up to 5 days]
  • Frequency of peri-operative morbidity after resection [Time frame: At day of discharge, assessed of up to 5 days]
  • Kind of peri-operative morbidity after resection [Time frame: At day of discharge, assessed of up to 5 days]
  • Assessment of the circumferential resection margin (CRM) [Time frame: At day of discharge, assessed up to 5 days]
  • Number of resected lymphnodes [Time frame: During surgery]
  • Assessment of pelvic function before and after rectal resection [Time frame: 15 months]
  • Rectal sphincter function before and after rectal resection [Time frame: 15 months]
  • Assessment of the difficulty of the preparation [Time frame: 48 hours after surgery]
  • Assessment of usability of guidance system [Time frame: Through study completion, an average of 6 months]

Eligibility criteria

Inclusion criteria

  • Patients with rectal cancer scheduled for robot-assisted rectal resection
  • Intact preoperative urogenital/rectal function
  • Full capability of consent

Exclusion criteria

  • Previous/Second malignant disease <5 years before diagnosis of rectal cancer
  • Previous abdominal surgery, except for laparoscopic appendectomy, laparoscopic cholecystectomy or Cesarean section
  • Pregnant or breastfeeding women
  • Addiction or illness that prevent the person concerned from assessing the nature and scope of the clinical trial and its possible consequences
  • indication that the participant is unlikely to comply with the trial protocoll (e.g. lack of compliance)
  • official or court order for involuntary hospitalization

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

Germany · 1 center
  • Department of Visceral, Thoracic and Vascular Surgery University Hospital Carl Gustav Caru — Dresden

Identifiers

NCT: NCT05652361 · TUD-COBOT2-087 · DE-25-00015527

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗